KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Operations (2016 - 2026)

Medtronic (MDT) has disclosed Cash from Operations for 13 consecutive years, with 2744000000.0 as the latest value for Q1 2026.

  • Quarterly Cash from Operations rose 6.69% to 2744000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7285000000.0 through Jan 2026, changed 0.11% year-over-year, with the annual reading at 7044000000.0 for FY2025, 3.79% up from the prior year.
  • Cash from Operations hit 2744000000.0 in Q1 2026 for Medtronic, up from 925000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2777000000.0 in Q2 2024 to a low of 661000000.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 1700705882.35 across 5 years, with a median of 1574000000.0 in 2023.
  • Biggest five-year swings in Cash from Operations: crashed 47.88% in 2022 and later surged 57.18% in 2024.
  • Year by year, Cash from Operations stood at 922000000.0 in 2022, then decreased by 28.31% to 661000000.0 in 2023, then soared by 44.93% to 958000000.0 in 2024, then fell by 3.44% to 925000000.0 in 2025, then soared by 196.65% to 2744000000.0 in 2026.
  • Business Quant data shows Cash from Operations for MDT at 2744000000.0 in Q1 2026, 925000000.0 in Q4 2025, and 1088000000.0 in Q3 2025.